Casper Medical CGuard EPS Stent 2023 Investor Presentation

Casper Medical presents its CGuard EPS Stent platform with proprietary MicroNet technology for carotid artery disease and stroke prevention. The company highlights superior clinical outcomes, expanding global commercial presence across 30 countries, and a near-term FDA approval pathway with potential for significant market growth in the $1.3B treated and $8B untreated markets.